WebThe TIPS may lead to a symptomatic improvement in 70–80% of patients with refractory hydrothorax. 57-60 However, shunt occlusion and hepatic encephalopathy are common complications encountered after the TIPS placement (25% and 31% of patients, respectively, in a large series). 60 The worsening of pre-existing pulmonary hypertension may also ... WebHepatic hydrothorax is defined as a transudative pleural effusion, usually greater than 500 mL in patients with portal hypertension without any other underlying primary cardio …
Hepatic hydrothorax - Cardenas - 2004 - Wiley Online Library
WebOne therapy used for refractory hydrothorax is tunneled pleural catheters (Harris & Chalhoub, 2012), which are used for the management of refractory malignant effusions. The risk of infection is theoretically reduced because the catheters are tunneled, and it is a closed system. Furthermore, because they are designed for periodic use, the rate ... Hepatic hydrothorax is a rare form of pleural effusion that occurs in people with liver cirrhosis. It is defined as an effusion of over 500 mL in people with liver cirrhosis that is not caused by heart, lung, or pleural disease. It is found in 5-10% of people with liver cirrhosis and 2-3% of people with pleural effusions. It is much more common on the right side, with 85% of cases occurring on the right… smwia local 47
The successful treatment of symptomatic, refractory hepatic hydrothorax …
Webwith Cirrhosis with refractory ascites and Hepatic Hydrothorax: who, w hat, and w hen? Jody C. Olson, M.D. Complications of decompensated cirrhosis include as-cites and hepatic hydrothorax (HH). Ascites is the most common manifestation of hepatic decompensation,1 and approximately 10% to 20% of patients will experience re- WebRefractory ascites is a frequent complication of advanced cirrhosis and is associated with hepatorenal syndrome and hepatic hydrothorax. Large volume paracentesis and … WebHepatic hydrothorax (HH) is defined as a transudative pleural effusion, usually >500 mL, in a cirrhotic patient without an underlying cardiopulmonary or pleural disease. 1 The estimated prevalence of HH is around 4% to 6% in cirrhotics. 2 The only definitive treatment of HH is liver transplantation.Other management strategies include sodium restriction, diuretics, … smwia local 25